Doximity price target raised to $80 from $58 at Goldman Sachs

Goldman Sachs analyst David Roman raised the firm’s price target on Doximity (DOCS) to $80 from $58 and keeps a Neutral rating on the shares after its Q3 earnings beat. The company’s revenue was the clear upside driver, and incremental margin flow through drove EBITDA margin to an all-time high of 60.5%, the analyst tells investors in a research note. Doximity’s revenue trends also showed continued momentum, with strong leading indicators that included selling seasons wins and large customer adds, the firm added.